New models aim to predict liver disease in HIV patients

NCT ID NCT06940375

Completed Knowledge-focused Sponsor: Shanghai Public Health Clinical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 315 HIV-positive adults to build models that predict fatty liver disease and liver scarring. Researchers used ultrasound and FibroScan tests to track liver changes over time. The goal was to better understand and identify liver problems early in people living with HIV.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC STEATOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome cirrhosis of liver fatty liver disease fibrotic liver disease HIV infectious disease metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease metabolic syndrome X

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATIC STEATOSIS HIV LIVER FIBROSIS MAFLD MASH METABOLIC SYNDROME (METS)

Contacts and locations

Locations

Shanghai Public Health Clinical Center

Shanghai, Shanghai Municipality, 201508, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.